Spectrum of Fibrotic Lung Diseases
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
This review covers fibrotic pulmonary diseases. Although idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases other than IPF. The biology, clinical presentation, and treatment of the more common disorders are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“UIP pattern on HRCT is also associated with worse outcomes in many ILDs, although for rheumatoid arthritis-ILD some debate exists on pattern versus extent of involvement on HRCT.(197, 216)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [197]
Citations
Cites
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.138461 · Cited by 4,941
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Self-citationDiagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Self-citationvan den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci‐Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38098 · Cited by 3,409
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
Self-citationLederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Valeyre, D., Prasse, A., Nunes, H., Uzunhan, Y., Brillet, P.-Y., & Müller-Quernheim, J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60680-7 · Cited by 1,087
Raghu, G., Remy-Jardin, M., Ryerson, C. J., Myers, J. L., Kreuter, M., Vasakova, M., Bargagli, E., Chung, J. H., Collins, B. F., Bendstrup, E., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-2032st · Cited by 1,047
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Maher, T. M., Corte, T. J., Fischer, A., Kreuter, M., Lederer, D. J., Molina-Molina, M., Axmann, J., Kirchgaessler, K.-U., Samara, K., Gilberg, F., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30341-8 · Cited by 629
Self-citationPredicting Survival Across Chronic Interstitial Lung Disease
Ryerson, C. J., Vittinghoff, E., Ley, B., Lee, J. S., Mooney, J. J., Jones, K. D., Elicker, B. M., Wolters, P. J., Koth, L. L., King, T. E., et al. (2014) · Chest · doi:10.1378/chest.13-1474 · Cited by 558
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Juge, P.-A., Lee, J. S., Ebstein, E., Furukawa, H., Dobrinskikh, E., Gazal, S., Kannengiesser, C., Ottaviani, S., Oka, S., Tohma, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801562 · Cited by 520
Self-citationGrunewald, J., Grutters, J. C., Arkema, E. V., Saketkoo, L. A., Moller, D. R., & Müller-Quernheim, J. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0096-x · Cited by 479
Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management
Vasakova, M., Morell, F., Walsh, S., Leslie, K., & Raghu, G. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2201pp · Cited by 456
Systemic sclerosis-associated interstitial lung disease
Perelas, A., Silver, R. M., Arrossi, A. V., & Highland, K. B. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30480-1 · Cited by 422
Chang, Y.-C., Yu, C.-J., Chang, S.-C., Galvin, J. R., Liu, H.-M., Hsiao, C.-H., Kuo, P.-H., Chen, K.-Y., Franks, T. J., Huang, K.-M., et al. (2005) · Radiology · doi:10.1148/radiol.2363040958 · Cited by 369
Rheumatoid arthritis-associated lung disease
Shaw, M., Collins, B. F., Ho, L. A., & Raghu, G. (2015) · European Respiratory Review · doi:10.1183/09059180.00008014 · Cited by 366
Burnham, E. L., Janssen, W. J., Riches, D. W. H., Moss, M., & Downey, G. P. (2014) · European Respiratory Journal · doi:10.1183/09031936.00196412 · Cited by 365
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Figliozzi, S., Masci, P. G., Ahmadi, N., Tondi, L., Koutli, E., Aimo, A., Stamatelopoulos, K., Dimopoulos, M., Caforio, A. L. P., & Georgiopoulos, G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13362 · Cited by 361
What's in a name? That which we call IPF, by any other name would act the same
Wells, A. U., Brown, K. K., Flaherty, K. R., Kolb, M., & Thannickal, V. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.00692-2018 · Cited by 352
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
Raghu, G., Chen, S.-Y., Hou, Q., Yeh, W.-S., & Collard, H. R. (2016) · European Respiratory Journal · doi:10.1183/13993003.01653-2015 · Cited by 338
Fibrosing interstitial lung diseases: knowns and unknowns
Cottin, V., Wollin, L., Fischer, A., Quaresma, M., Stowasser, S., & Harari, S. (2019) · European Respiratory Review · doi:10.1183/16000617.0100-2018 · Cited by 336
Self-citationManagement of interstitial lung disease associated with connective tissue disease
Mathai, S. C., & Danoff, S. K. (2016) · BMJ · doi:10.1136/bmj.h6819 · Cited by 328
Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
Karimi-Shah, B. A., & Chowdhury, B. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500526 · Cited by 316
Prevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Duchemann, B., Annesi-Maesano, I., Jacobe de Naurois, C., Sanyal, S., Brillet, P.-Y., Brauner, M., Kambouchner, M., Huynh, S., Naccache, J. M., Borie, R., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02419-2016 · Cited by 304
Palliative care in interstitial lung disease: living well
Kreuter, M., Bendstrup, E., Russell, A.-M., Bajwah, S., Lindell, K., Adir, Y., Brown, C. E., Calligaro, G., Cassidy, N., Corte, T. J., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30383-1 · Cited by 264
Self-citationProgressive fibrosing interstitial lung diseases: current practice in diagnosis and management
Wijsenbeek, M., Kreuter, M., Olson, A., Fischer, A., Bendstrup, E., Wells, C. D., Denton, C. P., Mounir, B., Zouad-Lejour, L., Quaresma, M., et al. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1647040 · Cited by 261
Self-citationFibrosis: ultimate and proximate causes
Thannickal, V. J., Zhou, Y., Gaggar, A., & Duncan, S. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74368 · Cited by 242
Visca, D., Mori, L., Tsipouri, V., Fleming, S., Firouzi, A., Bonini, M., Pavitt, M. J., Alfieri, V., Canu, S., Bonifazi, M., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30289-3 · Cited by 235
Olson, A. L., Gifford, A. H., Inase, N., Fernández Pérez, E. R., & Suda, T. (2018) · European Respiratory Review · doi:10.1183/16000617.0077-2018 · Cited by 200
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Wolters, P. J., Blackwell, T. S., Eickelberg, O., Loyd, J. E., Kaminski, N., Jenkins, G., Maher, T. M., Molina-Molina, M., Noble, P. W., Raghu, G., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30007-9 · Cited by 196
Paterniti, M. O., Bi, Y., Rekić, D., Wang, Y., Karimi-Shah, B. A., & Chowdhury, B. A. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-458oc · Cited by 194
Adegunsoye, A., Oldham, J. M., Bellam, S. K., Montner, S., Churpek, M. M., Noth, I., Vij, R., Strek, M. E., & Chung, J. H. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201807-443oc · Cited by 161
Raghu, G., Flaherty, K. R., Lederer, D. J., Lynch, D. A., Colby, T. V., Myers, J. L., Groshong, S. D., Larsen, B. T., Chung, J. H., Steele, M. P., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30059-1 · Cited by 157
Ley, B., Torgerson, D. G., Oldham, J. M., Adegunsoye, A., Liu, S., Li, J., Elicker, B. M., Henry, T. S., Golden, J. A., Jones, K. D., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201902-0360oc · Cited by 125
Behr, J., Neuser, P., Prasse, A., Kreuter, M., Rabe, K., Schade-Brittinger, C., Wagner, J., & Günther, A. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0462-y · Cited by 120
Barnett, J. L., Molyneaux, P. L., Rawal, B., Abdullah, R., Hare, S. S., Vancheeswaran, R., Desai, S. R., Maher, T. M., Wells, A. U., & Devaraj, A. (2019) · European Respiratory Journal · doi:10.1183/13993003.00531-2019 · Cited by 97
Cottin, V. (2019) · European Respiratory Review · doi:10.1183/16000617.0109-2019 · Cited by 86
Self-citationUnclassifiable interstitial lung diseases: Clinical characteristics and survival
Hyldgaard, C., Bendstrup, E. M., Wells, A. U., & Hilberg, O. (2016) · Respirology · doi:10.1111/resp.12931 · Cited by 83
Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease
Wijsenbeek, M. S., Holland, A. E., Swigris, J. J., & Renzoni, E. A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0614pp · Cited by 82
Self-citationIntegrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Adegunsoye, A., Vij, R., & Noth, I. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.011 · Cited by 80
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis
Walsh, S. L. F., Lederer, D. J., Ryerson, C. J., Kolb, M. R. J., Maher, T. M., Nusser, R., Poletti, V. E., Richeldi, L., Vancheri, C., WILSHER, M. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0493oc · Cited by 79
Self-citation“Velcro-type” crackles predict specific radiologic features of fibrotic interstitial lung disease
Sgalla, G., Walsh, S. L. F., Sverzellati, N., Fletcher, S., Cerri, S., Dimitrov, B., Nikolic, D., Barney, A., Pancaldi, F., Larcher, L., et al. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0670-0 · Cited by 76
Oxygen in patients with fibrotic interstitial lung disease: an international Delphi survey
Lim, R., Humphreys, C., Morisset, J., Holland, A. E., & Johannson, K. A. (2019) · European Respiratory Journal · doi:10.1183/13993003.00421-2019 · Cited by 61
Management of Fibrosing Interstitial Lung Diseases
Maher, T. M., & Wuyts, W. A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00992-9 · Cited by 48
Kolb, M. R. J., Raghu, G., & Wells, A. U. (2020) · European Respiratory Journal · doi:10.1183/13993003.00590-2020 · Cited by 2
Research works printed but not linked: 1
- George PM, Spagnolo P, Kreuter M, et al. Progressive fibrosing interstitial lung disease; consensus recommendations, clinical uncertainties and research priorities. Lancet Respir Med (in press).
Cited by
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Self-citationLeard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Self-citationWijsenbeek, M., Suzuki, A., & Maher, T. M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01052-2 · Cited by 539
Self-citationKadura, S., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0011-2021 · Cited by 328
Idiopathic pulmonary fibrosis: state of the art for 2023
Podolanczuk, A. J., Thomson, C. C., Remy-Jardin, M., Richeldi, L., Martinez, F. J., Kolb, M., & Raghu, G. (2023) · European Respiratory Journal · doi:10.1183/13993003.00957-2022 · Cited by 359
Metadata
- Authors
- Wijsenbeek, M., & Cottin, V.
- Affiliations
- Lyon 1 Université (FR)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-09-03
- Volume
- 383
- Issue
- 10
- Pages
- 958-968
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3082667512
- Semantic Scholar
- 2d06fb004ef8bc4d869d912b0dc5394e51fb7b38
- Cited by
- 736
- References
- 52
- Citations by year
- 2026: 81 · 2025: 153 · 2024: 138 · 2023: 145 · 2022: 117 · 2021: 95 · 2020: 7
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- fibrotic lung disease, idiopathic pulmonary fibrosis, pulmonary fibrosis, disease biology, clinical features, treatment
- MeSH terms
- Algorithms, Humans, Lung, Oxygen Inhalation Therapy, Pulmonary Fibrosis, Prevalence, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.